How Much Did Vim Raise?
Funding & Key Investors

Vim, a healthcare technology company, has secured significant enterprise-level funding, with its total funding reaching $60M. The company recently announced a major strategic investment of $60M, underscoring its pivotal role in advancing value-based care initiatives. This latest capital infusion is expected to accelerate Vim's mission to align incentives between healthcare payers and providers.

What is Vim?

Vim
SoftwareHealthcare Software

Vim operates a sophisticated healthcare technology platform designed to facilitate value-based care decisions by harmonizing the interests of payers and healthcare providers. Based in San Francisco, California, the company's innovative approach aims to streamline the transition towards more outcome-focused healthcare models. This strategic positioning allows Vim to address critical challenges in the healthcare ecosystem, fostering greater efficiency and improved patient outcomes through technology-driven solutions.

How much funding has Vim raised?

Vim has raised a total of $60M across 1 funding round:

2021

Series B

$60M

Series B (2021): $60M with participation from Premera Blue Cross, Optum Ventures, Frist Cressey Ventures, Great Point Ventures, Walgreens, Sequoia Capital, and Anthem Blue Cross and Blue Shield

Key Investors in Vim

Premera Blue Cross

Premera Blue Cross, a not-for-profit licensee of the Blue Cross Blue Shield Association, provides comprehensive health insurance products and services across Washington and Alaska, focusing on improving healthcare access and delivery.

Optum Ventures

Optum Ventures is an investment firm dedicated to transforming healthcare by backing early-stage companies that challenge the status quo and aim to create a better healthcare system for all.

Frist Cressey Ventures

Frist Cressey Ventures is a venture capital firm focused on accelerating the growth of innovative healthcare companies, providing capital and strategic support to drive systemic changes and improve patient outcomes.

What's next for Vim?

The substantial enterprise-level funding and recent strategic investment signal Vim's strong growth trajectory and market validation. This capital will likely be deployed to enhance its platform capabilities, expand its market reach, and forge deeper partnerships within the healthcare industry. Vim is poised to further solidify its position as a leader in value-based care technology, driving innovation and efficiency across the healthcare landscape.

See full Vim company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Healthcare SoftwareSoftwareBusiness ServicesSoftware TestingHealthcare ServicesProject ManagementMental Health & Rehabilitation Facilities
Healthcare SoftwareSoftware
Healthcare SoftwareSoftwareMobile App Development
Financial SoftwareSoftware

Frequently Asked Questions Regarding Vim Financial Insights

What are the most recent funding rounds that Vim has completed, and what were the funding rounds?
Vim has recently completed 1 funding rounds: Series B on May 5, 2021.
What is the total amount of funding Vim has raised to date?
Vim has raised a total of $60M in funding to date.
How many funding rounds has Vim completed?
Vim has completed 1 funding rounds.
How much funding did Vim raise in its most recent funding round?
Vim raised $60M in its most recent funding round.
Who are the lead investors in Vim's latest funding round?
The lead investor in Vim's latest funding round was Premera Blue Cross. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Vim's history?
The largest funding round in Vim's history was $60M.
See more information about Vim